New real-time PCR systems that fully integrate with cloud computing technology mark a new era in data sharing and global research collaboration. The Applied Biosystems QuantStudio 3 and QuantStudio 5 Real-Time PCR systems, designed to enable multi-institutional work across geographically dispersed teams, were debuted at the 2015 American Association for Cancer Research (AACR) Annual Meeting.
The new qPCR systems are the latest additions to the QuantStudio portfolio from Thermo Fisher Scientific. Designed for low- to mid-throughput laboratories conducting real-time PCR experiments, QuantStudio 3 and 5 are the first to connect to the Thermo Fisher Cloud computing platform, allowing applied and clinical researchers to learn, analyse, share, collaborate, and obtain support within a single platform. Researchers worldwide can now collaborate online in real-time, and access their data wherever and whenever necessary. Laboratories can also share experimental conditions and results with their partners, while providing a uniform experience for every user, and helping minimise training and errors.
With the Applied Biosystems QuantStudio 3 and QuantStudio 5 Real-Time PCR systems hosted on AWS, these PCR systems benefit from the inherent security of the AWS Cloud. The AWS Cloud infrastructure is architected for flexibility and security, and provides an extremely scalable, highly reliable platform that enables customers to deploy applications and data quickly and securely. Researchers using the PCR systems can access their work any time they have an Internet connection, without the need for subscription software.